| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Corporate Executive VP & CFO | Common Stock | 25.8K | $5.56M | $215.19 | Mar 3, 2022 | Direct |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Corporate Executive VP & CFO | Stock Options (Right to Buy) | 5.45K | $1.2M | $219.54 | Mar 3, 2022 | Direct |
| Fortrea Holdings Inc. | Director | Restricted Stock Unit | 13.6K | $500K | $36.70 | May 14, 2024 | Direct |
| Fortrea Holdings Inc. | Director | Restricted Stock Unit | 7.28K | $184K | $25.30 | Jul 18, 2024 | Direct |
| Fortrea Holdings Inc. | Director | Common Stock | 4.45K | $115K | $25.85 | Jul 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| FTRE | Fortrea Holdings Inc. | Jul 18, 2024 | 3 | -$49.3K | 4 | Jul 19, 2024 | Director |
| FTRE | Fortrea Holdings Inc. | May 14, 2024 | 1 | $0 | 4 | May 16, 2024 | Director |
| FTRE | Fortrea Holdings Inc. | Jul 18, 2023 | 1 | $0 | 4 | Jul 19, 2023 | Director |
| FTRE | Fortrea Holdings Inc. | Jun 15, 2023 | 0 | $0 | 3 | Jun 16, 2023 | Director |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Mar 3, 2022 | 11 | -$1.31M | 4 | Mar 4, 2022 | Corporate Executive VP & CFO |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Feb 28, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Corporate Executive VP & CFO |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Feb 22, 2022 | 2 | -$208K | 4 | Feb 24, 2022 | Corporate Executive VP & CFO |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Jan 28, 2022 | 2 | -$1.67M | 4 | Feb 1, 2022 | Corporate Executive VP & CFO |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Aug 9, 2021 | 2 | -$713K | 4 | Aug 10, 2021 | Corporate Executive VP & CFO |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | May 28, 2021 | 2 | $1.37M | 4 | Jun 2, 2021 | Corporate Executive VP & CFO |